Skip to main content
MedinCell S.A. logo

MedinCell S.A. — Investor Relations & Filings

Ticker · MEDCL ISIN · FR0004065605 LEI · 969500R79U6PXCL2FF46 PA Manufacturing
Open in API
Filings indexed 520 across all filing types
Latest filing 2025-07-24 Transaction in Own Shar…
Country FR France
Listing PA MEDCL

About MedinCell S.A.

https://www.medincell.com/en/

MedinCell S.A. is a pharmaceutical company at the commercial stage that specializes in the development of long-acting injectable (LAI) therapies. The company's core is its proprietary BEPO® technology platform, which enables the controlled and sustained release of active pharmaceutical ingredients over periods ranging from days to months after a single injection. This technology forms a fully biodegradable depot in situ, designed to improve treatment efficiency, enhance patient compliance, and increase the global accessibility of medicines. MedinCell develops a portfolio of LAI products across various therapeutic areas, including psychiatry, advancing its pipeline through both internal research and strategic partnerships with other pharmaceutical organizations.

Recent filings

Filing Released Lang Actions
Inside Information / Other news releases
Transaction in Own Shares Classification · 100% confidence The document is a press release from Medincell detailing the activity of its liquidity contract with Rothschild Martin Maurel for the first half of 2025. It provides a summary of share transactions (buy/sell) and the status of the liquidity account. This type of disclosure is a standard regulatory requirement for companies listed on Euronext to report on share buyback/liquidity programs. Since it reports on the company's own share transactions, it falls under the 'Transaction in Own Shares' category.
2025-07-24 English
Informations privilégiées / Autres communiqués
Transaction in Own Shares Classification · 100% confidence The document is a 'Bilan semestriel du contrat de liquidité' (Half-year liquidity contract report) for Medincell. It details the transactions (purchases and sales) conducted by the liquidity provider (Rothschild Martin Maurel) on behalf of the company over a specific period (January 1, 2025, to June 30, 2025). This type of disclosure is a standard regulatory requirement for companies listed on Euronext to report on their share buyback/liquidity programs. Since it is a periodic report on the company's own share transactions, it falls under the 'Transaction in Own Shares' category.
2025-07-24 French
Informations privilégiées / Autres communiqués
Share Issue/Capital Change Classification · 95% confidence The document is a standard regulatory disclosure required by Article 223-16 of the AMF General Regulation in France. It provides the total number of shares and voting rights for MedinCell as of June 30, 2025. This type of filing is a routine regulatory update regarding capital structure and voting rights, which does not fit into specific categories like M&A, dividends, or director dealings, making 'RNS' (Regulatory Filings) the most appropriate classification.
2025-07-03 French
Franchissement de seuil
Major Shareholding Notification Classification · 100% confidence The document is an official notice from the Autorité des marchés financiers (AMF) regarding a 'Déclaration de franchissement de seuil' (threshold crossing declaration). It details that Adage Capital Management LP has crossed below the 5% ownership threshold of Medincell. This falls directly under the definition of a Major Shareholding Notification (MRQ).
2025-06-19 French
Inside Information / News release on accounts, results
Earnings Release Classification · 98% confidence The document is titled "Medincell Publishes its Consolidated Annual Financial Results" and provides detailed consolidated financial statements, including the Income Statement, Balance Sheet, and Cash Flow statements for the fiscal year ending March 31, 2025, compared to 2024. This content structure, covering a full fiscal year with comprehensive financial tables, strongly indicates an Annual Report. Although it is presented as a 'Press Release' summarizing the results, the inclusion of the full IFRS consolidated statements (which are typically part of the 10-K filing in the US context, or the equivalent annual report filing elsewhere) suggests it contains the core content of the annual financial disclosure. Given the options, '10-K' is the closest match for a comprehensive Annual Report containing full financial statements for a fiscal year. It is not merely an Earnings Release (ER) as it contains full statements, nor is it an Interim Report (IR) as it covers the full year. FY 2025
2025-06-17 English
Informations privilégiées / Communiqué sur comptes, résultats
Earnings Release Classification · 100% confidence The document is titled "Medincell publie ses résultats financiers annuels consolidés" (Medincell publishes its consolidated annual financial results) and explicitly covers the fiscal year ending March 31, 2025. It contains detailed consolidated financial statements (Income Statement, Cash Flow, Balance Sheet) comparing the current 12-month period (31/03/2025) with the previous one (31/03/2024). This structure and content strongly indicate a comprehensive annual financial report. Although it is presented as a press release format, the inclusion of full IFRS consolidated statements for a full fiscal year aligns best with the definition of an Annual Report (10-K), even if the company is not strictly filing a US SEC 10-K, as this is the closest equivalent for a full-year financial disclosure in this classification scheme. It is not merely an Earnings Release (ER) because it includes full statements and detailed analysis, nor is it an Interim Report (IR) as it covers the full year. The length (over 24k characters) confirms it is the report itself, not just an announcement of the report (RPA/RNS). FY 2024
2025-06-17 French

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.